Atai Life Sciences Operating Expenses 2020-2024 | ATAI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Atai Life Sciences operating expenses from 2020 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Atai Life Sciences Operating Expenses 2020-2024 | ATAI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Atai Life Sciences operating expenses from 2020 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Related Stocks
Company Name	Market Cap
Fresenius SE (FSNUY)	$19.5B
Quest Diagnostics (DGX)	$18B
DaVita (DVA)	$12.9B
Encompass Health (EHC)	$10B
Chemed (CHE)	$8.2B
Elanco Animal Health (ELAN)	$6.6B
RadNet (RDNT)	$5.9B
Option Care Health (OPCH)	$3.7B
Amedisys (AMED)	$2.9B
LifeStance Health (LFST)	$2.8B
Astrana Health (ASTH)	$2.3B
Addus HomeCare (ADUS)	$2.2B
U.S Physical Therapy (USPH)	$1.4B
Aveanna Healthcare Holdings (AVAH)	$1.1B
Pennant (PNTG)	$1.1B
Daxor (DXR)	$43M
MEDIROM Healthcare Technologies (MRM)	$15M
Psychemedics (PMD)	$14M
ATI Physical Therapy (ATIP)	$8M
Ontrak (OTRK)	$8M
IMAC Holdings (BACK)	$1M